Medical Condition News

RSS

Study explores steroid prescribing rates for patients with inflammatory bowel disease

Steroid therapy is commonly used to treat acute attacks of the inflammatory bowel diseases ulcerative colitis and Crohn's disease; however, because it does not provide long-term benefits and it carries a risk of serious side effects, it should not be used to treat inflammatory bowel disease for more than three months.

9 Oct 2019

Paclitaxel-coated devices used for widening blocked arteries not linked to increased mortality

Devices coated with a drug called paclitaxel that are used for widening blocked arteries in legs and feet are safe and not linked to an increase in deaths, according to a study of nearly 65,000 patients, published in the European Heart Journal today (Wednesday).

9 Oct 2019

Melatonin may not help prevent delirium following major cardiac surgery

Delirium is observed in approximately 15% of hospitalized older adults, and it is more common in the critically ill and in those undergoing major surgery, such as heart surgery.

9 Oct 2019

Study evaluates role of PET/CT in selecting candidates for peptide receptor radionuclide therapy

A new study published in The Journal of Nuclear Medicine evaluated the role of 68Ga-DOTATATE positron emission tomography/computed tomography in selecting neuroendocrine tumor patients who may benefit from peptide receptor radionuclide therapy.

9 Oct 2019

New drug Aliskiren shows promise for heart failure patients

A study published in the International Journal of Molecular Sciences, as part of a special issue “Heart Failure: From Molecular Basis to Therapy”, in August 2019, shows that aliskiren, a drug approved by the US Food and Drug Administration (FDA), can improve survival for over 5 years, on average, and enhance life quality in patients who have been correctly diagnosed with heart failure.

9 Oct 2019

Dog owners live longer

Taking care of pets has been shown to provide a plethora of health benefits. Now, dog lovers may have a new reason to love their pets more as two new studies found that owning a dog is tied to a longer life, with a lower risk of premature death, especially among those who had a heart attack and stroke.

9 Oct 2019

IU research examines trends in public perceptions of violence in people with mental illness

In response to recent mass shootings and consistent public outcry, President Donald Trump's administration is considering a controversial proposal to monitor people with mental illness in hopes of preventing mass shootings.

8 Oct 2019

Pharmacist-Led Chronic Care Management Services model helps improve patient outcomes

With inhaler in hand, Dr. Cheng Yuet went over every detail to make sure the patient understood how the drug would control their COPD symptoms.

8 Oct 2019

Study may lead the way to decrease DLBCL relapse, development of second primary cancer

With improved treatments, especially the use of anti-cancer immunotherapies, more than two-thirds of all patients diagnosed with diffuse large B-cell lymphoma (DLBCL) will survive. However, after treatment, patients are at a small but real risk of developing a new cancer, called a second primary cancer.

8 Oct 2019

Study explores psychological aspects of pain management

An article in the current issue of Psychotherapy and Psychosomatics explores the psychological aspects of pain management with particular reference to placebo infusions in back pain.

8 Oct 2019

Combination treatment cures pancreatic cancer, reprograms the immune system

A University of Rochester Wilmot Cancer Institute research team reports that combining a type of radiation therapy with immunotherapy not only cures pancreatic cancer in mice, but appears to reprogram the immune system to create an "immune memory" in the same way that a vaccine keeps the flu away.

8 Oct 2019

Aliskiren drug can delay progression of congestive heart failure, lengthen survival rates

Researchers at the University of Arizona College of Medicine - Phoenix have shown for the first time in preclinical studies that Aliskiren, a drug that inhibits the enzyme that regulates blood pressure, can delay the progression of congestive heart failure and lengthen survival rates.

8 Oct 2019

Meflin protein plays a role in restraining progression of pancreatic cancer

A research team led by Nagoya University has revealed that cells containing a protein called Meflin have a role in restraining the progression of pancreatic cancer, a type of cancer that is hard to treat with traditional anti-cancer drugs.

8 Oct 2019

Biology and computers meld to help understand how breast cancer develops

Among the most deadly killers in the area of cancer, breast cancer is also extremely difficult to treat, once it has spread to the bones. Not only does it metastasize rapidly, but it comprises a variety of cell types and also depends on the input from many other non-breast cells during the initiation, growth and spread of the cancer. This complexity makes it more difficult to develop targeted therapies in this condition.

8 Oct 2019

Differences at the single-cell level can predict responses to BRAF inhibitor therapy

Patients with advanced melanoma have been able to live longer because of several newly approved targeted treatment options, including BRAF and MEK inhibitors. However, patients will often have different responses to the same treatment due to genetic variability.

8 Oct 2019

Deficit schizophrenics are physically different from other people

The study, published in Schizophrenia Bulletin on August 19, 2019, points out some differences in mouth structure in people with one form of schizophrenia called deficit schizophrenia, compared with other schizophrenics and non-schizophrenics.

8 Oct 2019

New understanding of breast cancer metastasis to bone

In breast cancer patients with metastatic disease, bone is the most common site of metastasis and the most common site of first distant relapse, with roughly half (48%) of breast cancer patients developing bone metastases after treatment.

8 Oct 2019

New study can help increase access, time to medication for opioid use disorder

A new study found that one in three young adults receive medication for opioid use disorder within 12 months of a non-fatal opioid overdose. The study, led by researchers at Boston Medical Center's Grayken Center for Addiction, in collaboration with the Massachusetts Department of Public Health, shows which medications - buprenorphine, methadone or naltrexone - are being taken, and how long after the overdose they receive the treatment.

8 Oct 2019

GUMC now offers three clinical trials to study treatments for LBD

Georgetown University Medical Center, a Lewy Body Dementia (LBD) Association Research Center of Excellence, is now offering three clinical trials to study new treatments for LBD, a disease often confused with Parkinson's and Alzheimer's disease.

8 Oct 2019

UTHealth: Psychedelic drug being studied to relieve treatment-resistant depression

Psilocybin, a psychedelic drug believed to help rewire the brain, is now being studied to relieve treatment-resistant depression at The University of Texas Health Science Center at Houston (UTHealth) as part of a global Phase II clinical trial.

8 Oct 2019

Medical Condition News

Study explores steroid prescribing rates for patients with inflammatory bowel disease

Paclitaxel-coated devices used for widening blocked arteries not linked to increased mortality

Melatonin may not help prevent delirium following major cardiac surgery

Study evaluates role of PET/CT in selecting candidates for peptide receptor radionuclide therapy

New drug Aliskiren shows promise for heart failure patients

Dog owners live longer

IU research examines trends in public perceptions of violence in people with mental illness

Pharmacist-Led Chronic Care Management Services model helps improve patient outcomes

Study may lead the way to decrease DLBCL relapse, development of second primary cancer

Study explores psychological aspects of pain management

Combination treatment cures pancreatic cancer, reprograms the immune system

Aliskiren drug can delay progression of congestive heart failure, lengthen survival rates

Meflin protein plays a role in restraining progression of pancreatic cancer

Biology and computers meld to help understand how breast cancer develops

Differences at the single-cell level can predict responses to BRAF inhibitor therapy

Deficit schizophrenics are physically different from other people

New understanding of breast cancer metastasis to bone

New study can help increase access, time to medication for opioid use disorder

GUMC now offers three clinical trials to study treatments for LBD

UTHealth: Psychedelic drug being studied to relieve treatment-resistant depression

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News